Characteristics and responses of EBV immortalized B cells from periodontal disease patients

Oral Diseases

Volumn 3, Issue 4, 1997, Pages 262-271

  Celenligil H ^a,b   Ebersole, J L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

A. actinomycetemcomitans; B cells; Epstein Barr virus; Immunoglobulin; Lipopolysaccharide; Periodontitis

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDE; MITOGENIC AGENT;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANTIBODY PRODUCING CELL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL IMMORTALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; PERIODONTITIS; PRIORITY JOURNAL;

EID: 0031423743     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.1997.tb00052.x     Document Type: Article

References (71)

1. Abderrazik M, Moynier M, Jefferis R et al (1992). Analysis of monoclonal rheumatoid factors obtained from the B-cell repertoire in rheumatoid arthritis. Scand J Immunol 35: 149-157.
2. Bouchereau J, Rousset F (1992). Human B lymphocytes: Phenotype, proliferation, and differentiation. Adv Immunol 52: 125-262.
3. Boylston AW, Gardner B, Anderson RL et al (1980). Production of human IgM anti-D in tissue culture by EB-virus-transformed lymphocytes Scand J Immunol 12: 355-362.
4. Campling BG, Cole SPC, Atlaw T et al (1987). Practical aspects of human-human hybridomas. In: Schook LB, ed. Monoclonal Antibody Production Techniques and Applications Marcel Dekker Inc: New York, pp 4-23.
5. Chan MA, Stein LD, Dosch HM, Sigal NH (1986). Heterogeneity of EBV-transformable human B lymphocyte populations. J Immunol 136: 106-112.
6. Clark EA, Ledbetter JA (1989). Structure, function and genetics of human B cell-associated surface molecules. Adv Cancer Res 52: 81-93.
7. Coligan JE, Kruisbeek AM, Margulies DH et al (1991). Immunologic studies in humans. In: Current Protocols in Immunology, John Wiley & Sons: New York, pp 7.1.1-7.1.4.
8. Crawford DH, Callard RE, Muggeridge MI et al (1983). Production of human monoclonal antibody to X31 influenza virus nucleoprotein. J Genet Virol 64: 697-700.
9. Dongari AI, Ebersole JL (1996). Production of inflammatory mediators and cytokines by human gingival fibroblasts following bacterial challenge. J Periodont Res 31: 90-98.
10. Ebersole JL (1990). Systemic humoral immune responses in periodontal disease. Crit Rev Oral Biol Med 1: 283-331.
11. Ebersole JL, Cappelli D (1995). Gingival crevicular fluid antibody to A. actinomycetemcomitans in periodontal disease. Oral Microbiol Immunol 9: 335-344.
12. Ebersole JL, Cappelli D, Sandoval M-N et al (1995). Antigen specificity of serum antibody in A. actinomycetemcomitans infected periodontitis patients. J Dent Res 74: 658-666.
13. Ebersole JL, Sandoval M-N, Steffen MJ et al (1991a). Serum antibody in Actinobacillus actinomycetemcomitans-infected patients with periodontal disease. Infect Immun 59: 1795-1802.
14. Ebersole JL, Sandoval M-N. Cappelli D (1994). Subgingival distribution of A. actinomycetemcomitans in periodontitis patients. J Clin Periodontol 21: 65-75.
15. Ebersole JL, Steffen MJ, Sandoval M-N et al (1991b). Antigenic specificity of gingival crevicular fluid antibody to A. actinomycetemcomitans. J Dent Res 70: 585.
16. Ebersole JL, Taubman MA (1994). The protective nature of host responses in periodontal diseases. Periodontology 2000 5: 112-141.
17. Ebersole JL, Taubman MA, Smith DJ (1985), Gingival crevicular fluid antibody to oral microorganisms. II. Distribution and specificity of local antibody responses. J Periodont Res 20: 349-356.
18. Fingeroth JD, Weis JJ, Tedder TF et al (1984). Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci 81: 4510.
19. Fior R, Vita N, Raphael M et al (1994). Interleukin-13 gene expression by malignant and EBV-transformed human B lymphocytes. Eur Cyto Net 5: 593-600.
20. Fives-Taylor P, Meyer DM, Sreenivasan PK et al (1994). Invasion of cultured epithelial cells by periodontopathogens. In: Genco R, Hamada S, Lehner T et al, eds. Molecular Pathogenesis of Periodontal Disease. American Society for Microbiology, Washington, DC, pp 57-68.
21. Frade R, Crevon MC, Barel M et al (1985). Enhancement of human B cell proliferation by an antibody to the C3d receptor, the gp140 molecule. Eur J Immunol 15: 73-78.
22. Gallagher G, Taylor N, Willdridge J (1987). Separate but complementary roles of the two forms of interleukin 1 in the growth of transformed human B lymphoblasts. Scand J Immunol 26: 295-301.
23. Genco RJ, Zambon JJ, Murray PA (1985). Serum and gingival fluid antibodies as adjuncts in the diagnosis of A. actinomycetemcomitans-associated periodontal disease. J Periodontol 56: 41-50.
24. Gordon J, Graeme G (1988). Control of human B-lymphocyte growth and differentiation. In: Bird G, Calvert JE, eds. B Lymphocytes in Human Disease. Oxford University Press: Oxford, England, pp 348-172.
25. Hall ER, Falkler WA Jr, Martin SA et al (1991). The gingival immune response to Actinobacillus actinomycetemcomitans in juvenile periodontitis. J Periodontol 62: 792-798
26. Hall ER, Martin SA, Suzuki JB et al (1994). The gingival immune response to periodontal pathogens in juvenile periodontitis. Oral Microbiol Immunol 9: 327-334.
27. Holt SC, Bramanti TE (1991). Factors in virulence expression and their role in periodontal disease pathogenesis. Crit Rev Oral Biol Med 2: 177-281.
28. Hunter KW, Jr (1985). Human monoclonal antibodies for prophylaxis and therapy of bacterial infections. In: Macario AJL, Conway de Macario E, eds. Monoclonal Antibodies Against Bacteria. Academic Press Inc: New York, pp 207-231.
29. Kishimoto T. Hirano T, Kuritani T et al (1978). Induction of IgG production in human B lymphoblastoid cell lines with normal human T cells. Nature 271: 756-759.
30. Kishimoto T, Hirano T, Taga T et al (1988). A new cytokine, BSF2/IL-6 and its receptor. In: Witte ON. Klinman NR, Howard MC et al, eds. B Cell Development. Liss Ine: New York, pp 157-171.
31. Lally ET, Baehni PC, McArthur WP (1980). Local immunoglobulin synthesis in periodontal disease. J Periodent Res 15: 159-164.
32. Lee SP, Wallace LE, Mackett M et al (1993). MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathways. Inter Immunol 5: 451-460.
33. Lorenzo PR, Kuwabara N, Kondo J et al (1995). IgE production by B-cells stimulated with interleukin-4 and Epstein-Barr virus in patients with elevated serum IgE levels. J Invest Allerg Clin Immunol 5: 78-81.
34. Lydyard PM, MacKenzie LE, Youinou PY et al (1992). Specificity and idiotope expression of IgM produced by CD5+ and CD5- cord blood B-cell clones. Ann NY Acad Sci 651: 527-539.
35. Machold KP, Carson DA, Lotz M (1993). Transforming growth factor-β (TGFβ) inhibition of Epstein-Barr virus (EBV)- and interleukin-4 (IL-4)-induced immunoglobulin production in human B lymphocytes. J Clin Immunol 13: 219-27.
36. Mackler BF, Frostad KB, Robertson PB et al (1977). Immunoglobulin bearing lymphocytes and plasma cells in human periodontal disease. J Periodont Res 12: 37-45.
37. Mangan DF, Won T, Lopatin DE (1983). Nonspecific induction of immunoglobulin M antibodies to periodontal disease-associated microorganisms after polyclonal human B-lymphocyte activation by Fusobacterium nucleatum. Infect Immun 41: 1038-1045.
38. Masoud H, Weintraub S, Cotter R et al (1990). Investigation on lipid A structure of Actinobacillus actinomycetemcomitans strains Y4 and human clinical isolate PO1021-7. Eur J Biochem 200: 775-779.
39. McArthur WP, Clark WB (1993). Specific antibodies and their potential role in periodontal diseases. J Periodontol 64: 807-818.
40. McCaughan GW, Brown MH, Callard RE (1986). Regulation of antibody production by an antigen-specific EBV-transformed B-lymphoblastoid cell line: effect of high-dose antigen and antigen-pulsed T cells. Immunology 58: 597-602.
41. Melchers F, Andersson J, Corbel C et al (1982). Regulation of B lymphocyte replication and maturation. J Cell Biochem 19: 315-320.
42. Morel F, Cohn Tanugi Cholley L, Brandolin G et al (1993). The O2-generating oxidase of B lymphocytes: Epstein-Barr virus-immortalized B lymphocytes as a tool for the identification of defective components of oxidase in chronic granulomatous disease. Biochim Biophys Acta 1182: 101-109.
43. Muraguchi A, Kishimoto T, Miki Y et al (1981). T cell replacing factor (TRF) induced secretion in a human B blastoid cell line, and demonstration of acceptors for TRF. J Immunol 127: 412-417.
44. Nakamura M, Burastero SE, Ueki Y et al (1988). Probing the normal and autoimmune B cell repertoire with Epstein-Barr virus: frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto's disease and systemic lupus erythematosis. J Immunol 141: 4165-4172.
45. Nilsson K, Klein G (1982). Phenotypic and cytogenic characteristics of human B-lymphoid cell lines and their relevance to the etiology of Burkitt's lymphoma. Adv Cancer Res 37: 319-326.
46. Ogawa T, McGhee ML, Moldoveanu Z et al (1989a). Bacteroides-specific specific IgG and IgA subclass antibody-secreting cells isolated from chronically inflamed gingival tissues. Clin Exp Immunol 76: 103-110.
47. Ogawa T, Tarkowski A, McGhee ML et al (1989b). Analysis of human IgG and IgA subclass antibody secreting cells from localized chronic inflammatory tissue. J Immunol 142: 1150-1158.
48. Ounanian A, Guilbert B, Seigneurin JM (1992). Characteristics of Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease and age-matched controls. Mech Ageing Develop 63: 105-116.
49. Page RC (1991). The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodont Res 26: 230-242.
50. Ranney RR (1991). Immunologic mechanisms of pathogenesis in periodontal diseases: an assessment. J Periodont Res 26: 243-254.
51. Ring CJA (1994). The B cell immortalizing functions of Epstein-Barr virus. J Gen Virol 75: 1-13.
52. Rosen A, Bergeley P, Jondal M et al (1977). Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature 267: 52-54.
53. Royston I, Sullivan JL, Periman PO et al (1975). Cell mediated immunity to Epstein-Barr virus transformed lymphoblastoid cells in acute infectious mononucleosis. New Engl J Med 297: 1159-1163.
54. Seymour GJ, Powell RN, Davies WIR (1979). Conversion of a stable T-cell lesion to a progressive B-cell lesion in the pathogenesis of chronic inflammatory periodontal disease. J Clin Periodontol 6: 267-277.
55. Shenker B (1987). Immunologic dysfunction in the pathogenesis of periodontal diseases. J Clin Periodontol 14: 489.
56. Sinclair AJ, Farrell PJ (1995). Host cell requirements for efficient infection of quiescent primary B lymphocytes by Epstein-Barr virus. J Virol 69: 5461-5468.
57. Smith DJ, Gadalla LM, Ebersole JL et al (1985). Gingival crevicular antibody to oral microorganisms. III. Association of gingival homogenate and gingival crevicular fluid antibody levels. J Periodont Res 20: 357-367.
58. Socransky SS, Haffajee AD (1994). Evidence of bacterial etiology: a historical perspective. Periodontol 2000 5: 7-25.
59. Spitznagel J, Kraig E, Kolodrubetz D (1991). Regulation of leukotoxin in leukotoxic and nonleukotoxic strains of Actinobacillus actinomycetemcomitans. Infect Immun 59: 1394-1401.
60. Steinitz M, Klein E (1981). Human monoclonal antibodies produced by immortalization with Epstein-Barr Virus. Immunol Today 2: 38-43.
61. Steubing PM, Mackler BF, Schur PH et al (1982). Humoral studies of periodontal disease I. Characterization of immunoglobulins quantitated from cultures of gingival tissue. Clin Immunol Immunopathol 22: 32-43.
62. Taichman NS, McArthur WP, Tsai C-C et al (1982). Leukocidal mechanisms of Actinobacillus actinomycetemcomitans. In: Genco RJ. Mergenhagen SE. eds. Host-Parasite Interactions in Periodontal Diseases. American Society of Microbiology: Washington, DC, pp 261-269
63. Teranishi T, Hirano T, Arima N et al (1982). Human helper T cell factors (THF). II. Induction of IgG production in B lymphoblastoid cell lines and identification of T cell replacing factor (TRF). J Immunol 128: 1903-1909.
64. Tew JG (1988). Periodontal disease: humoral immune mechanisms including specific and polyclonal. Clin Immunol Newslett 11: 188-190.
65. Tew JG, Engel D, Mangan D (1989). Polyclonal B-cell activation in periodontitis. J Periodont Res 24: 225-241.
66. Tew JG, Marshall DR, Burmeister JA et al (1985). Relationship between gingival crevicular fluid and serum antibody titers in young adults with generalized and localized periodontitis. Infect Immun 49: 487-493.
67. Tosata G (1987). The Epstein-Barr virus and the immune system. Adv Cane Res 49: 75-125.
68. Tosata G, Magrath I, Koski I et al (1979). Activation of suppressor T cells during Epstein-Barr virus induced infectious mononucleosis. N Engl J Med 301: 1133-1137.
69. Wallace LE, Rickinson AB, Rowe M et al (1982). Epstein-Barr virus-specific cytotoxic T cell clones restricted through single HLA antigen. Nature 297: 413-416.
70. Wang W, Napoli JL, Ballow M (1993). The effects of retinol on in vitro immunoglobulin synthesis by cord blood and adult peripheral blood mononuclear cells. Clin Exp Immunol 92: 164-168.
71. Yoshie H, Taubrnan MA, Ebersole JL et al (1985). Activation of rat B lymphocytes by Actinobacillus actinomycetemcomitans. Infect Immun 47: 264-270.